All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
September 2024: Updated once weekly oral methotrexate SMS for patients within adult gastroenterology services
News
September 2024: Updated once weekly oral methotrexate SMS for patients within adult gastroenterology services
Methotrexate drug entry: 8.4.3 Antifolates
The updated guideline covers the use of methotrexate for the treatment of the following indications: Maintenance of remission of severe Crohn's disease (unlicensed) and reducing risks of immunogenicity alongside anti-TNF treatments in the management of inflammatory bowel disease (unlicensed).
